| Dr Jeffrey H Margolis, MD | |
|
27301 Dequindre Rd, Suite314, Madison Heights, MI 48071-3473 | |
| (248) 399-4400 | |
| (248) 399-4840 |
| Full Name | Dr Jeffrey H Margolis |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 31 Years |
| Location | 27301 Dequindre Rd, Madison Heights, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871577544 | NPI | - | NPPES |
| 1871577544 | Medicaid | MI | |
| 700H217350 | Other | MI | BLUE SHIELD |
| 0633727 | Other | MI | BCBS INDIVIDUAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301075311 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Beaumont Hospital - Farmington Hills | Farmington hills, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Beaumont Hospital - Wayne | Wayne, MI | Hospital |
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michigan Healthcare Professionals Pc | 0345413258 | 448 |
News Archive
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Teva Pharmaceutical Industries and Lonza Group today announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars.
The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.
› Verified 6 days ago
| Entity Name | Michigan Healthcare Professionals Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295023547 PECOS PAC ID: 0345413258 Enrollment ID: O20111109000027 |
News Archive
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Teva Pharmaceutical Industries and Lonza Group today announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars.
The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.
› Verified 6 days ago
| Entity Name | Beaumont Medical Group- Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578072906 PECOS PAC ID: 7214299866 Enrollment ID: O20180320002549 |
News Archive
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Teva Pharmaceutical Industries and Lonza Group today announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars.
The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey H Margolis, MD 27301 Dequindre Rd, Suite 314, Madison Heights, MI 48071-3473 Ph: (248) 399-4400 | Dr Jeffrey H Margolis, MD 27301 Dequindre Rd, Suite314, Madison Heights, MI 48071-3473 Ph: (248) 399-4400 |
News Archive
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.
Teva Pharmaceutical Industries and Lonza Group today announced that following a strategic review of the Teva-Lonza Joint Venture (TL-JV), the companies have decided to discontinue their collaboration for the development, manufacturing and marketing of biosimilars.
The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.
Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.
› Verified 6 days ago
Dr. Gary Langnas, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 27483 Dequindre Rd, Suite 302, Madison Heights, MI 48071 Phone: 248-547-6603 Fax: 248-547-5696 | |
Dr. Savitha Balaraman, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Gary L Berg, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 27483 Dequindre Rd, Suite 210, Madison Heights, MI 48071 Phone: 248-398-4081 Fax: 248-398-4527 | |
Dr. Harold Margolis, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Robert E Reid Ii, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 27301 Dequindre Rd, Suite 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Michael Berkovic, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 27301 Dequindre Rd, Ste 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 | |
Dr. Stephen M Hoffman, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Suite 314, Madison Heights, MI 48071 Phone: 248-399-4400 Fax: 248-399-4840 |